Longwood Capital Partners

Acuta Capital Partners as of Dec. 31, 2025

Portfolio Holdings for Acuta Capital Partners

Acuta Capital Partners holds 30 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Terns Pharmaceuticals (TERN) 17.5 $26M 637k 40.40
Praxis Precision Medicines I (PRAX) 16.6 $25M 83k 294.74
Cidara Therapeutics Com New (CDTX) 13.4 $20M 89k 220.89
Ocular Therapeutix (OCUL) 8.7 $13M 1.1M 12.14
Aadi Bioscience (WHWK) 5.6 $8.3M 3.4M 2.42
Bright Minds Biosciences Com New (DRUG) 4.5 $6.6M 85k 78.04
Compass Therapeutics (CMPX) 4.0 $5.9M 1.1M 5.37
Jazz Pharmaceuticals Shs Usd (JAZZ) 3.3 $4.9M 29k 170.00
Insmed Com Par $.01 (INSM) 3.1 $4.5M 26k 174.04
Argen Se - Sponsored Adr (ARGX) 2.8 $4.1M 4.9k 840.95
Surrozen Com New (SRZN) 2.7 $4.0M 178k 22.60
Amylyx Pharmaceuticals (AMLX) 2.7 $4.0M 333k 12.08
Minerva Neurosciences Com New (NERV) 1.9 $2.9M 710k 4.02
Tango Therapeutics (TNGX) 1.7 $2.5M 283k 8.86
Taysha Gene Therapies Com Shs (TSHA) 1.7 $2.5M 455k 5.50
Zymeworks Del (ZYME) 1.4 $2.1M 80k 26.33
Oculis Holding Ordinary Shares (OCS) 1.4 $2.0M 102k 19.97
Design Therapeutics (DSGN) 1.0 $1.4M 151k 9.38
Inhibrx Biosciences (INBX) 0.9 $1.3M 16k 79.00
United Therapeutics Corporation (UTHR) 0.8 $1.1M 2.3k 487.25
Verastem Com New (VSTM) 0.8 $1.1M 143k 7.72
Maze Therapeatics (MAZE) 0.6 $829k 20k 41.43
Moonlake Immunotherapeutics Class A Ord (MLTX) 0.5 $781k 59k 13.18
Sutro Biopharma (STRO) 0.5 $780k 68k 11.57
Dianthus Therapeutics (DNTH) 0.5 $689k 17k 41.21
Revolution Medicines (RVMD) 0.5 $670k 8.4k 79.65
Lb Pharmaceuticals Com Shs (LBRX) 0.5 $668k 30k 22.26
Pasithea Therapeutics Corp Com New (KTTA) 0.4 $581k 450k 1.29
Unicycive Therapeutics (UNCY) 0.2 $346k 60k 5.77
Nuvation Bio Inc -cw27 *w Exp 07/07/2027 (NUVB.WS) 0.0 $30k 91k 0.33